These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22144367)

  • 21. [An enzymological contribution to the solution of the problem of manure].
    van Os JZ
    Tijdschr Diergeneeskd; 1991 Jun; 116(11):581-2. PubMed ID: 1647555
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular biology and biotechnology of bacteriophage.
    Onodera K
    Adv Biochem Eng Biotechnol; 2010; 119():17-43. PubMed ID: 19714316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Return of a killer. Phages may once again fight tough bacterial infections.
    Koerner BI
    US News World Rep; 1998 Nov; 125(17):51-2. PubMed ID: 10187346
    [No Abstract]   [Full Text] [Related]  

  • 24. Turning a new phage.
    Gravitz L
    Nat Med; 2012 Sep; 18(9):1318-20. PubMed ID: 22961150
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of bacterial contamination using acetate-tolerant Schizosaccharomyces pombe during bioethanol production from molasses.
    Saithong P; Nakamura T; Shima J
    J Biosci Bioeng; 2009 Sep; 108(3):216-9. PubMed ID: 19664555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Health and the environment in the face of advances in biotechnology].
    Lafontaine A
    Bull Mem Acad R Med Belg; 1984; 139(8-9):437-48. PubMed ID: 6535616
    [No Abstract]   [Full Text] [Related]  

  • 27. Bacteriophage host range and bacterial resistance.
    Hyman P; Abedon ST
    Adv Appl Microbiol; 2010; 70():217-48. PubMed ID: 20359459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phage therapy: harmless viruses help destroy bacterial infections].
    van Bergen M; Wagenaar J
    Tijdschr Diergeneeskd; 2008 Jul 15-Aug 1; 133(14-15):618-21. PubMed ID: 18767304
    [No Abstract]   [Full Text] [Related]  

  • 29. Mining manufacturing data for discovery of high productivity process characteristics.
    Charaniya S; Le H; Rangwala H; Mills K; Johnson K; Karypis G; Hu WS
    J Biotechnol; 2010 Jun; 147(3-4):186-97. PubMed ID: 20416347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of interactions between phage and bacterial proteins within the infected cell: a diverse and puzzling interactome.
    Roucourt B; Lavigne R
    Environ Microbiol; 2009 Nov; 11(11):2789-805. PubMed ID: 19691505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phage production and maintenance of stocks, including expected stock lifetimes.
    Fortier LC; Moineau S
    Methods Mol Biol; 2009; 501():203-19. PubMed ID: 19066823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Full enclosure needed to prevent contamination during pulmonary procedures.
    Health Devices; 1993 Dec; 22(12):594-5. PubMed ID: 8113077
    [No Abstract]   [Full Text] [Related]  

  • 33. Bacteriophage therapy in children: facts and prospects.
    Fortuna W; Miedzybrodzki R; Weber-Dabrowska B; Górski A
    Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Foam and its mitigation in fermentation systems.
    Junker B
    Biotechnol Prog; 2007; 23(4):767-84. PubMed ID: 17567037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phage host range and efficiency of plating.
    Kutter E
    Methods Mol Biol; 2009; 501():141-9. PubMed ID: 19066818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Containment: comprehensive assessment and integrated control.
    Van Houten J
    J Parenter Sci Technol; 1992; 46(1):22-4. PubMed ID: 1625106
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biohazard and its elimination in the pathological examinations].
    Shimada O
    Rinsho Byori; 1988 Jan; 36(1):35-9. PubMed ID: 3367520
    [No Abstract]   [Full Text] [Related]  

  • 38. Study of a virus-bacteria interaction model in a chemostat: application of geometrical singular perturbation theory.
    Poggiale JC; Auger P; Cordoleani F; Nguyen-Huu T
    Philos Trans A Math Phys Eng Sci; 2009 Dec; 367(1908):4685-97. PubMed ID: 19884175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodecontamination of a clinical laboratory.
    Brown JW; Blackwell H; Gulow LB
    MLO Med Lab Obs; 1992 Feb; 24(2):45-8. PubMed ID: 10119568
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vaccine prophylaxis: contribution for the control of biologic risk in exposed workers].
    Vonesch N; Tomao P; Signorini S; Palmi S; Papaleo B
    Med Lav; 2000; 91(3):226-50. PubMed ID: 10965671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.